Sun shines on Surya Pharma after GDR issue
Surya Pharmaceutical rose 1.48% at Rs 274.50 at 9:41 IST on BSE after the company said it raised $25 million from an issue of global depository receipts.
The announcement was made before trading hours today, 13 October 2010.
Meanwhile, the BSE Sensex was up 46.36 points, or 0.23%, to 20,249.70.
On BSE, 5,312 shares were traded in the counter as against an average daily volume of 2.11 lakh shares in the past one quarter.
The stock hit a high of Rs 275.50 and a low of Rs 271.50 so far during the day. The stock had hit a record high of Rs 314.85 on 25 August 2010 and a 52-week low of Rs 100.10 on 30 October 2009.
The stock had underperformed the market over the past one month till 12 October 2010, falling 6.21% compared with the Sensex's 7.47% jump. It had outperformed the market in past one quarter, soaring 46.57% as against 12.63% rise in the Sensex.
The small-cap pharmaceutical company has an equity capital of Rs 14.47 crore. Face value per share is Rs 10.
The company said the global depository receipts (GDR) issue was priced at Rs 290 per share, a 7.2% premium over Tuesday's (12 October 2010) closing price of Rs 270.50.
Surya Pharmaceutical's net profit jumped 74.6% to Rs 23.35 crore on 72% increase in net sales to Rs 357.76 crore in Q1 June 2010 over Q1 June 2009.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment